购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-86 (Compound 188) 作为一种羟基类型的17β-脱氢酶 13 (HSD17B13) 抑制剂,其 IC50 值不超过 0.1 μM。此化合物主要用于研究肝病、代谢性疾病和心血管疾病,例如非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 及药物性肝损伤 (DILI)。
HSD17B13-IN-86 (Compound 188) 作为一种羟基类型的17β-脱氢酶 13 (HSD17B13) 抑制剂,其 IC50 值不超过 0.1 μM。此化合物主要用于研究肝病、代谢性疾病和心血管疾病,例如非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪性肝炎 (NASH) 及药物性肝损伤 (DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Compound 188 (HSD17B13-IN-86) serves as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating potency with an IC50 value of ≤ 0.1 μM against estradiol. This compound is applicable in the study of various conditions including liver, metabolic, and cardiovascular diseases, specifically NAFLD, NASH, and drug-induced liver injury (DILI) [1]. |
分子量 | 476.34 |
分子式 | C20H15Cl2N5O3S |
CAS No. | 2770247-78-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.